StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > OMFUG! Am I Reading This Right??!!

<< Previous

Bullboard Posts

Next >>

Comment by Photoman77on Nov 09, 2021 8:11pm

117 Views

Post# 34107599

RE:RE:RE:RE:RE:OMFUG! Am I Reading This Right??!!

Let's start by closing the open gap at $1.25

That is the first major milestone. Then we can assess from there depending on news flow.

This has been a slow trickle down month after month with lack of news but now that the ducts are all lining up, the move up can be swift when it starts.

It's no coincidence that Noel Atkinson (Clarus Securities) who covers SZLS has his PT sitting at $1.25

Aristotle sales combined with Avrt financials will determine how hard we push past that PT.

<< Previous

Bullboard Posts

Next >>

Investing with insurance and protection